idiopathic pulmonary fibrosis

IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome
Jaume Bordas-Martínez, Ricard Gavaldà, Jessica Shull, √anesa Vicens-Zygmunt, Lurdes Planas-Cerezales, Guadalupe Bermudo-Peloche, Salud Santos, Neus Salord, Carmen Monasterio, Guillermo Suarez-Cuartin, Maria Molina-Molina

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3745; DOI: 10.1183/13993003.congress-2021.PA3745
Frequency of observed interstitial lung disease in a secondary care hospital in the North West of England
Shan L Liew, Conal Hayton, Zoe Borrill, Hou Law, Georges Ng Man Kwong

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3759; DOI: 10.1183/13993003.congress-2021.PA3759
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
Ying Qiu, Julia Zhu, Brandon Elpers, Jenny Jiang, Adesuwa Ogbomo, Rajesh Mallampati, Clare Byrne, Jackson Tang, Aryeh Fischer

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3762; DOI: 10.1183/13993003.congress-2021.PA3762
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Masuda Norestani, M. Norestani, N. Hoyer, Z. Barrella Harboe, S.B. Shaker

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3755; DOI: 10.1183/13993003.congress-2021.PA3755
PFBIO EXA: A prospective cohort of respiratory hospitalization in IPF patients
Emilia K.A. Åttingsberg, Nils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, Saher Shaker

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3752; DOI: 10.1183/13993003.congress-2021.PA3752
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
Olha Shchudro, Ksenia Bielosludtseva, Tetyana Pertseva, Lyudmila Konopkina, Mariia Krykhtina, Lyudmyla Konopkina

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3900; DOI: 10.1183/13993003.congress-2021.PA3900
Pro-fibrotic phenotype of human Hermansky-Pudlak syndrome lung fibroblasts
Bernadette Gochuico, Jennifer Wang, Lily Smith, Jasmina Abdalla, Meixing Zuo, Tesiya Franklin, Shachar Abudi, Resat Cinar, May Malicdan, Chen Han

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3613; DOI: 10.1183/13993003.congress-2021.PA3613
All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2
Matthew Watson, Thomas McLellan, Muhunthan Thillai

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3747; DOI: 10.1183/13993003.congress-2021.PA3747
Unclassifiable Interstitial Lung Disease (ILD). Why?
Elizabeth De Freitas Gonzalez, Carmen López Garay, Cristina Menéndez Sánchez, Carlos Mier Bango, Pablo Franco Suárez, Laura Sierra Herranz, Elena Bollo De Miguel, Javier Juan García, Nieves Alonso Orcajo, Juan Ignacio López Fernández, Silvia Fernández Huerga

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3756; DOI: 10.1183/13993003.congress-2021.PA3756
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Annika Hummersgaard Hansen, Joachim Høg Mortensen, Sarah Rank Rønnow, Morten Karsdal, Anne-Christine Bay-Jensen, Diana Julie Leeming, Jannie Marie Bülow Sand

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3697; DOI: 10.1183/13993003.congress-2021.PA3697

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us